✉news WorldUS Politics first seen 1 d ago, last 1 d ago, peak #27
PharmaEssentia to Present BESREMi Data at Myeloproliferative Neoplasms Congress
Original: PharmaEssentia to Present Data at 18th International Congress on Myeloproliferative Neoplasms Highlighting Unmet Need with Current Therapies and Real-World Use of BESREMi® in Essential Thrombocythemia and Polycythemia Vera
PharmaEssentia will present new data at the 18th International Congress on Myeloproliferative Neoplasms. The presentations will highlight unmet needs with current therapies and real-world use of BESREMi in treating essential thrombocythemia and polycythemia vera, two rare blood cancers. The findings aim to support broader use of the drug in clinical practice.
Why now: The company has announced its upcoming congress presentations, drawing attention from investors and clinicians focused on blood cancer treatments.
PharmaEssentiaBESREMi18th International Congress on Myeloproliferative Neoplasms
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2869924